Publishing research using ab5662? Please let us know so that we can cite the reference in this datasheet.
ab5662 has been referenced in 3 publications.
Cozzo AJ et al.cMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer.Springerplus 5:348 (2016).
Castoldi R et al.Molecular characterization of novel trispecific ErbB-cMet-IGF1R antibodies and their antigen-binding properties.Protein Eng Des Sel 25:551-60 (2012).
Smotrov N et al.Development of a cell-based assay for measurement of c-Met phosphorylation using AlphaScreen technology and high-content imaging analysis.J Biomol Screen 14:404-11 (2009).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"